These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound. Peng JY; Vaidehi N; Hall SE; Goddard WA ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941 [TBL] [Abstract][Full Text] [Related]
10. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site. Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086 [TBL] [Abstract][Full Text] [Related]
11. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography. Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478 [TBL] [Abstract][Full Text] [Related]
12. Structure-Based Design and Discovery of New M Fish I; Stößel A; Eitel K; Valant C; Albold S; Huebner H; Möller D; Clark MJ; Sunahara RK; Christopoulos A; Shoichet BK; Gmeiner P J Med Chem; 2017 Nov; 60(22):9239-9250. PubMed ID: 29094937 [TBL] [Abstract][Full Text] [Related]
13. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor. Espinoza-Fonseca LM; Trujillo-Ferrara JG FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776 [TBL] [Abstract][Full Text] [Related]
15. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs). Kuduk SD; Beshore DC Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125 [TBL] [Abstract][Full Text] [Related]
16. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor. Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650 [TBL] [Abstract][Full Text] [Related]
17. Diverse Effects on M Rook JM; Abe M; Cho HP; Nance KD; Luscombe VB; Adams JJ; Dickerson JW; Remke DH; Garcia-Barrantes PM; Engers DW; Engers JL; Chang S; Foster JJ; Blobaum AL; Niswender CM; Jones CK; Conn PJ; Lindsley CW ACS Chem Neurosci; 2017 Apr; 8(4):866-883. PubMed ID: 28001356 [TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor. Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists. Rajeswaran WG; Cao Y; Huang XP; Wroblewski ME; Colclough T; Lee S; Liu F; Nagy PI; Ellis J; Levine BA; Nocka KH; Messer WS J Med Chem; 2001 Dec; 44(26):4563-76. PubMed ID: 11741475 [TBL] [Abstract][Full Text] [Related]
20. Rational design of partial agonists for the muscarinic m1 acetylcholine receptor. Chen X; Klöckner J; Holze J; Zimmermann C; Seemann WK; Schrage R; Bock A; Mohr K; Tränkle C; Holzgrabe U; Decker M J Med Chem; 2015 Jan; 58(2):560-76. PubMed ID: 25478907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]